Avetina Medicines Private Limited
About Avetina Medicines Private Limited
Data last updated:
Avetina Medicines Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 2016.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2016PTC274840.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Prabhat Shripal Saxena and Ramachandra Nayak.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Mumbai, Maharashtra.
Company details
Contact details
Avetina Medicines Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB – 310 Shree Krishna Commercial Centre Near Lilya Nagar Near Kamat Club Goreg, Aon (West), Mumbai, Maharashtra, India – 400062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avetina Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Avetina Medicines Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avetina Medicines Private Limited, buy the company report.
Board of directors of Avetina Medicines Private Limited
Avetina Medicines has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhat Shripal Saxena Also directs: Glopharm Laboratories Private Limited | Director | 23 Mar 2016 | 10 Years 7 Months | As last reported |
| Ramachandra Nayak | Director | 23 Mar 2016 | 10 Years 7 Months | As last reported |
Legal cases
No court or tribunal cases involving Avetina Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avetina Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avetina Medicines Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avetina Medicines Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Prabhat Shripal Saxena was appointed as Director on 23 Mar 2016.
Frequently asked questions
Avetina Medicines has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Avetina Medicines was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 23 March 2016 and is registered under CIN U24231MH2016PTC274840. The company has been struck off by the Registrar of Companies and is no longer operational.
Avetina Medicines had 2 directors:
- Prabhat Shripal Saxena - Director
- Ramachandra Nayak - Director
The CIN (Corporate Identification Number) of Avetina Medicines is U24231MH2016PTC274840. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Avetina Medicines is at B – 310 Shree Krishna Commercial Centre Near Lilya Nagar Near Kamat Club Goreg, Aon West, Mumbai, Maharashtra, India – 400062.
Avetina Medicines was incorporated on 23 March 2016. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Avetina Medicines on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2016 are in the company report.
Avetina Medicines operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Prabhat Shripal Saxena was appointed as Director on 23 Mar 2016. Ramachandra Nayak was appointed as Director on 23 Mar 2016.
The compliance status of Avetina Medicines is compliant as of 13 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
